Why Non-Metal Cancer Markers Like VM1 Are Redefining Long-Term Breast Care

January 6, 2026

Discover why non-metal markers, especially advanced polymer-based designs like VizMark’s VM1, are rapidly becoming the preferred option

In modern breast cancer diagnostics, tissue marking plays a decisive role in ensuring accurate follow-up, treatment planning, and longitudinal imaging. For decades, metallic clips, usually made of titanium, stainless steel, nickel, or nitinol, have been the standard option used after biopsies to mark the site of a suspicious lesion. These legacy devices can introduce significant imaging artifacts, fundamentally compromising diagnostic sensitivity and reliability near the biopsy site

Today, the field is shifting. Non-metal markers, especially advanced polymer-based designs like VizMark’s VM1, are rapidly becoming the preferred option because they offer clearer imaging, improved biological compatibility, and predictable visibility across all modalities. For patients, this translates into safer monitoring, fewer imaging complications, and far more reliable long-term care.

Below is a detailed look at why metal markers are increasingly seen as outdated and why VM1 non-metal marker represents the future of precision breast imaging.

The Limitations of Metal Markers Over Time

Metal clips may seem simple, but their interaction with soft tissue creates several long-term issues that affect diagnostics and patient comfort.

1. Biological Constraints

Metal interacts with the human body in ways that can distort both tissue and imaging over time.

Foreign Body Reaction

Metallic implants can trigger:

  • Local inflammation
  • Distortion of the original biopsy site

Over time, these reactions can mimic abnormalities, complicating interpretation of future scans.

Corrosion and Ion Release

Nickel, chromium, and other alloy components can slowly leach into tissue. This increases the risk of:

  • Hypersensitivity reactions
  • Chronic irritation

These effects, while sometimes subtle, matter enormously in long-term oncology follow-up.

Marker Migration

Metal is rigid and does not conform to the natural movement of breast tissue. As the tissue shifts due to compression, motion, or healing, the marker can:

2. Procedural and Workflow Constraints

Metallic clips also introduce complications unrelated to biology.

Cross-Modality Limitations

Metal behaves very differently on various imaging platforms:

  • Mammography: extremely radiopaque → may mask microcalcifications
  • Ultrasound: causes acoustic shadowing → obscures the lesion
  • MRI: creates susceptibility voids → loss of diagnostic detail

This inconsistency forces radiologists to mentally “translate” the marker’s appearance between modalities, adding unnecessary interpretation risk.

MRI Restrictions

Metal markers must be labeled MRI-conditional, which:

  • Adds administrative burden
  • Requires precise documentation
  • May delay urgent MRI scheduling
  • Still produces artifacts even when considered safe

For a patient who needs ongoing imaging for years, these limitations create friction that should not exist.

Why Non-Metal Markers, Especially VM1, Solve These Problems

Newer materials like hydrogel, zirconia ceramic, bioabsorbable polymers, and carbon-coated ceramics introduce crucial advantages for long-term care. VizMark’s VM1, in particular, was engineered to excel across all three critical dimensions: biology, visibility, and workflow efficiency.

Superior Biological Compatibility

Non-metal materials are inherently inert and do not release ions. VM1’s composition:

  • Minimizes tissue reaction
  • Avoids fibrotic capsule formation
  • Eliminates allergy risks associated with nickel or chromium
  • Remains stable without migrating

This stability is essential for reliable surveillance over months or decades.

Artifact-Free, Multi-Modality Visibility

VM1 was purpose-built for seamless imaging:

Mammography: Opaque, masking detail (with metal markers) - Clear, non-obstructive (with VM1)

Ultrasound: Acoustic shadowing (with metal markers)- Clean borders, no artifacts (with VM1)

MRI: Susceptibility voids (with metal markers) - Artifact-free, fully MRI-safe (with VM1)

3D Tomo: May cause blooming (with metal markers) - Consistent visibility (with VM1)

Instead of creating new problems, VM1 is visible without interference, exactly what radiologists need for confident diagnosis.

Optimized for Long-Term Monitoring

Metal clips remain permanently, affecting tissue and imaging indefinitely. VM1 avoids these issues because:

  • It remains stable without distorting tissue
  • It does not mimic lesions
  • It does not affect radiation planning
  • It supports consistent multi-year surveillance
  • Documentation burdens are drastically reduced

This is particularly important for dense-breasted patients, who often require multiple imaging modalities and more frequent follow-up.

The Future: Non-Metal Markers as Standard of Care

As breast imaging evolves, with more MRI, 3D mammography, and multi-modality workflows, metallic markers increasingly feel like relics of a previous era. Their limitations are inherent to the material itself, meaning no redesign can fully eliminate their drawbacks.

VM1 and other advanced non-metal markers were created specifically to align with modern oncology needs:

  • Precision navigation
  • Long-term tissue preservation
  • Clarity across all imaging platforms
  • Minimal biological disruption

For patients, this means safer procedures, cleaner imaging, and more predictable long-term monitoring.

FAQ

1. Are non-metal breast markers safe for MRI?

Yes. VM1 and other non-metal markers introduce no magnetic interactions and avoid the susceptibility artifacts typically caused by metal clips.

2. Can non-metal markers migrate like metal ones?

Migration is significantly reduced. VM1’s material properties allow it to remain stable within soft tissue, even during compression or natural breast movement.

3. Do non-metal markers interfere with mammograms?

No. Unlike radiopaque metal clips, VM1 remains visible without obscuring microcalcifications or early-stage abnormalities.

4. Why are non-metal markers better for long-term follow-up?

They avoid chronic inflammation, eliminate ion release concerns, produce clean images across all modalities, and ensure consistent lesion localization for years.

Join the Revolution in Women’s Health

As VM-1 sets a new standard for post-biopsy care, we’re not just improving technology—we’re improving lives.

About VizMark

Our team, led by radiologist and women’s health advocate Dr. Michael T. Nelson, created VM-1 improve imaging under MRI necessary for high risk patients. Through years of research and collaboration, we’ve designed a marker that eliminates the challenges of traditional solutions, offering better outcomes for patients and providers alike.

Dr. Michael Nelson
Founder and primary inventor, Dr. Nelson is a Board-Certified Radiologist, former U.S. Navy Flight Surgeon, and Professor of Radiology at the University of Minnesota. A leader in Mammography, Interventional Radiology, and Women’s Health, he co-founded the Jane Brattain Breast Center at Park Nicollet Medical Center.

Dr. Michael Nelson

Founder, Chief Medical Officer, and radiology expert

Kim Nelson
Accomplished senior executive and board member with 30+ years in high-tech, leading business growth, revenue expansion, and successful exits, including roles at Oracle and Primus Knowledge (IPO).

Kim Nelson

CEO with a proven track record of driving innovation

Tom Murphy
With 30+ years in medical device sales, operations, and management, Mr. Murphy has deep expertise in the tumor marker space, leading operations and sales at Mermaid Medical, Argon Medical, and Angiotech.

Tom Murphy

VP of Operations, tumor marker specialist

Steve Karel
A biotech senior executive with startup experience, Mr. Karel has held roles as CEO, CFO, and SVP of Business Development. He brings expertise in finance, fundraising, corporate development, and R&D, strengthening VizMark’s operations and growth.

Steve Karel

CFO with deep expertise in medical finance

Contact VizMark

Learn more, get pricing, and explore how VM-1 can help patients and doctors.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.